Subject: VPH Newsletter: November 2019

The EC has launched an online survey to share views on the revised version of the "Orientations towards the first Strategic Plan for Horizon Europe" document. The deadline for contribution is 17 November 2019
On 25 October 2019, an interview between Euractiv and Dr. Julia Fentem, the head of Unilever’s Safety and Environmental Assurance Centre (SEAC), was published in Euractiv’s special report on “Alternatives on animal testing”.
On 22 October 2019, the director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Nathalie Moll published an article entitled “Living with rare disease: hope for the future, access today”.
On 10 October 2019, Ingrid Klingmann, Chairman of the European Forum for Good Clinical Practice (EFGCP), published a guest blog entry on the website of the European Federation of Pharmaceutical Industries and Associations (EFPIA) entitled “How big is the need for cross-border access to clinical trials?”.
On 10 October 2019, the European Commission published some guidelines on Good Clinical Practice specific to Advanced Therapy Medicinal Products
At the recent General Assembly held in Paris on 4 Oct 2019, the election process of the new Board of Trustees of the VPHi Institute was finalised.
The VPHi is leading a working group in collaboration with representatives of EMA and a number of experts from different fields to identify the most appropriate tools for verifying and validating in silico models in drug development.
The VPHi has recently opened the call for bids to host the VPH2022 conference. Interested organisations should submit their proposal by February 28th, 2020.
A new interesting position paper has been published by Prof Viceconti and all on the credibility of predictive models and the regulatory science aspects of in silico medicine. A must read for anyone working in the field!
The European Commission has published an article promoting the EU-funded InSilc project aiming to create an in silico clinical trials platform for designing and developing drug-eluting BVS.
Application deadline 20 December 2019
Application deadline 18 November 2019
13 - 15 January 2020, Sheffield - U.K. 
21 - 25 February 2020, Frankfurt - Germany - Research paper submission deadline: 5 February 2020
11 - 13 March 2020, Munster - Germany - Registration deadline 1 February 2020
12 - 15 July 2020, Milan - Italy - Abstract submission deadline 31 January 2020
26 - 28 August 2020, Paris - France - Save the date!
"The Virtual Physiological Human will revolutionise the way health knowledge is produced stored and managed as well as the way in which healthcare is currently delivered."
 European Commission
LikeTwitterPinterestGooglePlus LinkedInForward
Celestijnenlaan 300C, 3001, Heverlee, Belgium
You may unsubscribe or change your contact details at any time.